期刊文献+

2014年重庆医科大学附属第一医院细菌耐药性监测 被引量:7

Bacterial drug resistance surveillance in First Affiliated Hospital of Chongqing Medical University during 2014
下载PDF
导出
摘要 目的了解重庆医科大学附属第一医院临床分离菌对常用抗菌药物的耐药性。方法对该院2014年1~12月收集的临床分离菌进行细菌药物敏感试验,结果按美国临床和实验室标准协会(CLSI)2014年版标准判断。结果临床分离菌共7 740株,其中革兰阳性菌占29.4%,革兰阴性菌占70.6%。金黄色葡萄球菌和凝固酶阴性葡萄球菌中甲氧西林耐药株分别为30.2%和77.2%。葡萄球菌属中甲氧西林耐药株对主要药物的耐药率显著高于甲氧西林敏感株,未发现对万古霉素及利奈唑胺耐药的菌株。肠球菌属中粪肠球菌对主要抗菌药物的耐药率低于屎肠球菌,屎肠球菌有少数万古霉素耐药株(2.3%),出现少数耐利奈唑胺的粪肠球菌(0.9%)。大肠埃希菌、肺炎克雷伯菌中产超广谱β-内酰胺酶(ESBLs)的阳性分别为59.5%和31.8%。肠杆菌科细菌对碳青霉烯类抗菌药物仍高度敏感,总耐药率小于2.0%。铜绿假单胞菌对亚胺培南和美罗培南耐药率分别为24.5%和17.9%,鲍曼不动杆菌对两者的耐药率分别为71.9%和75.0%。多重耐药肺炎克雷伯菌和鲍曼不动杆菌增加明显。结论细菌耐药性严重,尤其是多重耐药菌对临床构成严重威胁。合理选用抗菌药物,加强感染控制措施是当务之急。 Objective To investigate the resistance of clinically isolated bacteria to commonly used antibacterial drugs in the First Affiliated Hospital of Chongqing Medical University.Methods The bacterial susceptibility testing in clinically isolated bacteria collected during January to December 2014 was carried out.The detection results were judged according to the standards by CLSI in 2014.Results Among 7 740 clinical isolated strains of bacteria collected during this period,Gram negative bacteria and Gram positive bacteria accounted for 70.6% and 29.4% respectively.Methicillin resistant(MR)strains in S.aureus and coagulase negative Staphylococcus accounted for 30.2% and 77.2% respectively.The resistance rates of MR strains to main antimicrobial agents were much higher than those of methicillin sensitive(MS)strains.No staphylococcal strain was resistant to vancomycin or linezolid.The resistance rates of E.faecalis strains to main antibacterial agents was much lower than those of E.faecium.Some strains(2.3%)of E.faecium were found resistant to vancomycin,while some strains(0.9%)of E.faecalis were found resistant to linezolid.The ESBLs producing strains were 59.5%in Escherichia coli and 31.8%in Klebsiella pneumoniae.Strains of Enterobacteriaceae were highly susceptible to imipenem and meropenem,the overall resistance rates being less than 2.0%.Resistance rates of P.aeruginosa to imipenem and meropenem were 24.5% and 17.9%,respectively.The resistance rates of A.baumanii to the two carbapenems were 71.9% and 75.0%,respectively.The multi-drug resistant K.pneumoniae and A.baumanii were increased markedly.Conclusion Bacterial drug resistance is serious,especially the multi-drug resistant bacteria constitute a serious threat to clinic.Therefore it is urgent to strengthen the infection control measures.
出处 《国际检验医学杂志》 CAS 2016年第13期1755-1756,1759,共3页 International Journal of Laboratory Medicine
基金 国家临床重点专科建设项目[财社2010(305)号]
关键词 细菌耐药性监测 细菌药物敏感试验 多重耐药菌 bacterial resistance surveillance bacterial drug susceptibility testing multi-drug resistant bacteria
  • 相关文献

参考文献7

  • 1Martins A, Hunyadi A, Amaral L. Mechanisms of resist- ance in bacteria: an evolutionary approach[J]. Open Mi- crobiol J,2013,7(12) :53-58.
  • 2胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
  • 3Yang Q,Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased sus-ceptibility to carbapenems., results from large hospital- based surveillance studies in China[J]. Antimicrob Agents Chemother,2010,54(1) :573-577.
  • 4Davies J,Davies D. Origins and evolution of antibiotic re- sistance[J]. Microbiol Mol Biol Rev, 2010,74 (3) : 417.
  • 5阳苹,夏云.葡萄球菌感染的临床分布及耐药性分析[J].重庆医学,2012,41(30):3167-3168. 被引量:7
  • 6Pourakbari B,Aghdam MK, Mahmoudi S,et al. High fre- quency of vancomyein-resistant enterocoeeus faeealis in an Iranian referral children medical hospital[J]. M0edica, 2012,7(3) :201-204.
  • 7牛司强,阳苹,张莉萍.2012年重庆市细菌耐药性监测[J].中国抗生素杂志,2014,39(5):338-343. 被引量:15

二级参考文献25

  • 1Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 3Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 4Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 5Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 6Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 7Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
  • 8Nefise O, Mustafa AC, Esragul A, et al. Risk factors for ICU-acquired methicillin-resistant staphylococcus aureus infections[J]. Am J Infect Con, 2006,34 (1) : 1-5.
  • 9Bozdogan B, Ednie L, Crdeito K, et al. Derivatives of a vancomycin-resistant staphylococcus aureus strain isola- ted at hershey medical center[J]. Antimicrob Chemother, 2004,48(12) :4762-4765.
  • 10Martins A, Hunyadi A, Amaral L. Mechanisms of resistance in bacteria: an evolutionary approach[J]. Open MicrobiolJ, 2013, 7: 53-58.

共引文献542

同被引文献69

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部